 Since that time, many other examples have been identified.Terfenadine, the first non-sedating antihistamine, had to be withdrawn from the market because of the small risk of a serious side effect.However, terfenadine was discovered to be the prodrug of the active molecule, fexofenadine, which does not carry the same risks as the parent compound.